Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804049 · ClinicalTrials.gov registry record · Phase 1
Metformin and Muscle in Insulin-resistant Older Veterans
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
NCT01804049: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT01804049 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01804049, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
Sarcopenia is the loss of muscle mass, strength and function with aging and is associated with increased disability, falls and fractures. Older adults with diabetes and prediabetes are insulin resistant and have a higher risk of developing sarcopenia. This study examines the use of metformin, an antidiabetic drug, for preventing the development of sarcopenia in older adults with prediabetes.
Interventions
- DRUG placebo
- DRUG metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-04-08 |
| Est. Completion | 2018-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01804049
The ClinicalTrials.gov registry entry for NCT01804049 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01804049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01804049 about?
NCT01804049 is a clinical study titled "Metformin and Muscle in Insulin-resistant Older Veterans". Sarcopenia is the loss of muscle mass, strength and function with aging and is associated with increased disability, falls and fractures. Older adults with diabetes and prediabetes are insulin resistant and have a higher risk of developing sarcopenia. This study examines the use of metformin, an ant...
What is the current status of trial NCT01804049?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2014-04-08. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT01804049?
The interventions under investigation include: placebo (DRUG), metformin (DRUG).
Who is sponsoring clinical trial NCT01804049?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.